CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Myriad Genetics, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Myriad Genetics, Inc.
320 S Wakara Way
Phone: (801) 584-3600p:801 584-3600 SALT LAKE CITY, UT  84108-1214  United States Ticker: MYGNMYGN

Business Summary
Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to enable optimal treatment, or assess a patient's risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology. Its molecular diagnostic tests include myRisk Hereditary Cancer, BRACAnalysis CDx and COLARIS.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20206/30/2019YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board S. LouisePhanstiel 61 3/23/2020 9/16/2009
Interim President, Interim Chief Executive Officer, Chief Financial Officer, Treasurer R. BryanRiggsbee 48 2/6/2020 10/1/2014
Independent Vice Chairman of the Board Walter M.Gilbert 87 3/1/1992
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Counsyl, Inc. 180 Kimball Way South San Francisco CA United States
Crescendo Bioscience 341 Oyster Point Blvd South San Francisco CA United States
AssureRx Health, Inc. 6030 S. Mason Montgomery Road Mason OH United States
Myriad RBM, Inc. 3300 Duval Road Austin TX United States

Business Names
Business Name
AssureRx Canada, Ltd
AssureRx Health, Inc.
Assurex Health, Inc.
16 additional Business Names available in full report.

General Information
Number of Employees: 2,600 (As of 6/30/2019)
Outstanding Shares: 74,554,701 (As of 5/1/2020)
Shareholders: 28,416
Stock Exchange: NASD
Federal Tax Id: 870494517
Fax Number: (801) 584-3640
Email Address: investor@myriad.com


Copyright © 2020 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, August 8, 2020